This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cadila Pharmaceuticals Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations by Kumud Kumar Padhee in Pharmaceutical Composition
Introduction
Kumud Kumar Padhee is an accomplished inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for treating atherosclerosis. His work focuses on enhancing the efficacy and safety of multi-component pharmaceutical formulations.
Latest Patents
Kumud Kumar Padhee holds a patent for a stable pharmaceutical composition aimed at treating atherosclerosis. This invention involves a solid oral multi-component composition that combines blood pressure-lowering drugs with lipid-lowering agents and optionally a platelet aggregation inhibitor in a single dosage form. The formulation is designed to overcome drug-drug interactions, exhibit favorable pharmacokinetic and pharmacodynamic profiles, and minimize side effects. The invention aims to improve adherence to therapy by maintaining the activity of all active ingredients without significantly increasing the adverse event profile.
Career Highlights
Kumud Kumar Padhee is associated with Cadila Pharmaceuticals Limited, where he applies his expertise in pharmaceutical innovation. His work has contributed to advancements in drug formulations that address critical health issues, particularly cardiovascular diseases.
Collaborations
Kumud has collaborated with notable colleagues, including Bakulesh Mafatlal Khamar and Nilamkumari Somalal Patel, to further enhance the research and development efforts at Cadila Pharmaceuticals Limited.
Conclusion
Kumud Kumar Padhee's innovative work in pharmaceutical compositions demonstrates his commitment to improving healthcare solutions. His contributions are vital in the ongoing efforts to develop effective treatments for complex medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
